Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Cetuximab × Clear all

NCT00728663 2019-05-14

Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00448097 2016-03-17

Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy

Phase 2 Terminated

Prostatic Neoplasms